Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Eduardo Cazap, MD PhD (President SLACOM)

ISSN: 1754-6605
Submit article
Articles
Editorials
Special issues
Author interviews
690-postoperative-radiotherapy-in-the-management-of-keloids
Claudia C Carvajal, Carla M Ibarra, Douglas L Arbulo, Moisés N Russo, Claudio P Solé
689-next-generation-metronomic-chemotherapy-report-from-the-fifth-biennial-international-metronomic-and-anti-angiogenic-therapy-meeting-6-8-may-2016-mumbai
Pan Pantziarka, Lisa Hutchinson, Nicolas André, Sébastien Benzekry, Francesco Bertolini, Atanu Bhattacharjee, Shubhada Chiplunkar, Dan G Duda, Vikram Gota, Sudeep Gupta, Amit Joshi, Sadhana Kannan, Robert Kerbel, Mark Kieran, Antonella Palazzo, Aparna Parikh, Eddy Pasquier, Vijay Patil, Kumar Prabhash, Yuval Shaked, Giselle Saulnier Sholler, Jaroslav Štěrba, David J Waxman, Shripad Banavali
688-predictors-of-survival-of-natural-killer-t-cell-lymphoma-nasal-type-in-a-non-asian-population-a-single-cancer-centre-experience
Jule Vásquez, Mariana Serrano, Lourdes Lopez, Cristian Pacheco, Shirley Quintana
687-the-cost-of-cancer-care-is-not-related-to-its-outcomes
Guy Storme, S Dhaese, D Corens, Mark De Ridder
686-close-cooperation-with-health-technology-assessment-expertise-is-crucial-for-implementation-and-ultimately-reimbursement-of-innovations-in-oncology
WH van Harten, VP Retèl
685-health-technology-assessment-and-value-the-cancer-value-label-cavala-methodology
Francisco Rocha-Gonçalves, Marina Borges, Patrícia Redondo, José Laranja-Pontes
684-next-generation-sequencing-in-nsclc-and-melanoma-patients-a-cost-and-budget-impact-analysis
Rosa A van Amerongen, Valesca P Retèl, Veerle MH Coupé, Petra M Nederlof, Maartje J Vogel, Wim H van Harten
683-innovations-that-reach-the-patient-early-health-technology-assessment-and-improving-the-chances-of-coverage-and-implementation
WH van Harten, VP Retèl
682-comparison-between-standard-and-reduced-volume-radiotherapy-in-bladder-preservation-trimodality-protocol-for-muscle-invasive-bladder-cancer-patients
Waleed Arafat, Azza Darwish, George E Naoum, Wael Sameh, Gamal El Husseiny, Fathy Abd-El-Gawad, Mostafa Samir
681-phosphoethanolamine-and-the-danger-of-unproven-drugs
Noam Pondé, Evandro de Azambuja, Felipe Ades

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation